Latest Posts

Efficient control of leukaemia with treatment by dual immune-checkpoint blockade

cll, immune checkpoint, immunotherapy, marina wierz, etienne moussay, jérôme paggetti
Chronic lymphocytic leukaemia (CLL) is a haematological malignancy that originates in the blood-forming cells of the bone marrow.
April 17, 2018   In Our News  

Associating frailty to cardiovascular disease and mortality

frailty, frailty scores, gloria aguayo, cardiovascular disease, cancer
Frailty is common in elderly people with cardiovascular disease and goes along with elevated mortality.
April 09, 2018   In Our News  

Funding from Lions Club Luxembourg for a research project on lung cancer

lung cancer, ppm, victoria el khoury, egfr inhibitors, drug resistance
Dr Victoria El Khoury and Prof Rolf Bjerkvig from LIH's Department of Oncology were granted funding by “Action LIONS Vaincre le Cancer”.
April 06, 2018   In Our News  

LIH researchers report the current knowledge on immune-metabolism in two prestigious reviews

immune-metabolism, davide franchina, dirk brenner
The Experimental and Molecular Immunology research group at LIH’s Department of Infection and Immunity recently issued two review articles in Cell press.
April 05, 2018   In Our News  

Creation of LuxGen: a sequencing centre for Luxembourg

gunnar dittmar, luxgen, sequencing centre, ngs, luxembourg
To accelerate biomedical research in Luxembourg, LIH and the “Laboratoire national de santé” (LNS) teamed up to create LuxGen, a national sequencing centre.
March 28, 2018   In Our News  

LIH Science Quest - the lay public on a scientific mission

lih science quest, juliette pertuy
From 23rd to 25th February, LIH held a large science-promoting event, the first of its kind in Luxembourg.
March 27, 2018   In Our News  

Translating innovative research results for the benefit of society

rkto, research knowledge, business development, kits
LIH has been successful with the submission of a proposal for the Knowledge & Innovation Transfer Support (KITS) funding scheme of the FNR.
March 21, 2018   In Our News  

The Cancer Foundation supports a research project on glioma cell invasion

fondation cancer, simone niclou, glioma cell invasion, anne schuster, norlux
The Cancer Foundation (Fondation Cancer) funds a research project of the NorLux Neuro-Oncology Laboratory at LIH’s Department of Oncology.
March 12, 2018   In Our News  

Vision of Department Head Prof Laetitia Huiart: improve health and change lifestyles

laetitia huiart, population health, clinical research, translational research, public health
LIH has a new director to lead its Department of Population Health - a cornerstone of the institute and its development towards translational research.
March 02, 2018   In Our News  

LIH participated in the DREAM Challenges

dream challenges, francisco azuaje, biomod, proteogenomics
Bioinformaticians at LIH’s Department of Oncology took part in the Proteogenomics challenge organised by the DREAM Challenges.
February 28, 2018   In Our News  

Two LIH researchers on scientific leave share their experience

danielle perez bercoff, tatiana michel, inter mobility
Dr Tatiana Michel and Dr Danielle Perez Bercoff, both principal investigators, had the opportunity during 2016 and 2017 to benefit from a scientific leave.
February 21, 2018   In Our News  

FNR CORE funding for five research projects at LIH

core funding, gunnar dittmar, christiane hilger, maria ruiz-castell, petr nazarov, yvan devaux
The Luxembourg National Research Fund (FNR) supports multi-annual thematic research programmes with its central funding instrument CORE.
February 16, 2018   In Our News  

Multiannual framework agreement signed - new objectives for LIH

framework agreement, biomedical research, multiannual agreement, performance contract
On 25th January 2018, the new framework agreement for the period from 2018 to 2021 between LIH and the Luxembourg Government was signed.
February 13, 2018   In Our News  

Tumour-inducing capacity found in sleeping cancer cells

tumour-inducing capacity, senescence, lymphoma, gunnar dittmar
A ground-breaking study involving LIH was published in Nature in December 2017.
February 08, 2018   In Our News  

First INTER FNR-DFG grant for LIH for a research project in oncology

etienne moussay, b cell lymphoma, extracellular vesicles
The Luxembourg National Research Fund (FNR) committed funding to more than 20 bi- and multilateral projects via its INTER scheme in 2017.
February 06, 2018   In Our News  

Retrospective 2017: highpoints for LIH

retrospective, personalised medicine, ulf nehrbass
LIH made numerous important contributions to biomedical science in 2017.
February 01, 2018   In Our News  

Autophagy as potential target against glioblastoma

autophagy, glioblastoma, atg9a, anna golebiewska, norlux
Glioblastoma is a highly aggressive brain tumour against which existing treatments are largely inefficient.
January 23, 2018   In Our News  

Insights into the metabolic disorder in IDH-mutant gliomas

idh mutation, glioma, fred fack
Researchers from LIH’s Department of Oncology characterised in depth the metabolic landscape of glial tumours carrying an IDH mutation.
January 17, 2018   In Our News  

Pelican grants for PhD candidates to support training and mobility in brain cancer research

pelican grant, glioblastoma, matthieu gobin, mohamad sarmini, andrés cano
Andrés Cano Galiano and Matthieu Gobin, PhD candidates at LIH’s Department of Oncology, are two of the successful applicants for the Pelican Grant 2017.
January 15, 2018   In Our News  

Winners of the “Pump Prime” grant announced at the PMC retreat

pmc, personalised medicine, brice appenzeller, annette kuehn, allergen-derived peptides
For the seventh time, Luxembourg-based researchers and clinicians met on 4th December 2017 for the annual retreat of the Personalised Medicine Consortium (PMC).
January 04, 2018   In Our News